Advertisement

Parenteral Nutrition in Advanced Cancer

  • Edward M. CopelandIII
Living reference work entry

Abstract

Nutritional repletion by gastrointestinal tract or central vein has now been established to replenish or preserve lean body mass which prevents multiple complications in treatments with chemotherapy, surgery, and radiation therapy. These treatments may result in catabolism with the inability to repair wounds, to mount an appropriate chemotactic response to infection, or to avoid the effects of immunosuppression. Total parenteral nutrition can reverse catabolism in the appropriately selected patients. Patients with advanced cancer already have altered metabolism that can result in all the complications of malnutrition. An attempt to treat these patients with any form of anticancer therapy that results in further catabolism may result in the need to place these patients in an intensive care unit. The purpose of this chapter is to present the data in a historical fashion that proves the salutary effect of nutritional repletion. The evidence is provided that patients with advanced cancer can withstand treatment appropriate for their malignancy, have the chance for a positive tumor response, and have a significantly reduced chance of untoward complications of malnutrition secondary to the selected anticancer therapy.

Keywords

Central Venous Catheter Skin Test Infectious Complication Lean Body Mass Malnourished Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

List of Abbreviations

5-FU

5-Fluorouracil

BMT

Bone marrow transplant

EPA

Eicosapentaenoic acid

g/100 ml

Grams per 100 ml

ICU

Intensive care unit

IVH

Intravenous hyperalimentation

MDAH

MD Anderson Hospital and Tumor Institute

TPN

Total parenteral nutrition

References

  1. Arfons LM, Lazarus HM. Total parenteral nutrition and hematopoietic stem cell transplantation: an expensive placebo. Bone Marrow Transplant. 2005;36:281–8.CrossRefPubMedGoogle Scholar
  2. Bozetti F, Gavazzi C, Miceli R, et al. Perioperative total parenteral nutrition in malnourished, gastrointestinal cancer patients: a randomized, clinical trial. J Parenter Enteral Nutr. 2000;24:7–14.CrossRefGoogle Scholar
  3. Bozzetti F, Braga M, Gianotti L, et al. Postoperative enteral versus parenteral nutrition in malnourished patients with gastrointestinal cancer: a randomized multicenter trial. Lancet. 2001;358:1487–92.CrossRefPubMedGoogle Scholar
  4. Brennan MF, Pisters PWT, Posner M, et al. A prospective randomized trial of total parenteral nutrition after major pancreatic resection for malignancy. Ann Surg. 1994;220:436–40.PubMedCentralCrossRefPubMedGoogle Scholar
  5. Burnette B, Jatoi A. Parenteral nutrition in patients with cancer: recent guidelines and a need for further study. Curr Opin Support Palliat Care. 2010;4:1–4.CrossRefGoogle Scholar
  6. Copeland EM, Dudrick SJ. Nutritional aspects of cancer. In: Hickey RC, editor. Current problems in cancer, vol. 1, No. 3. Chicago: Year Book Medical Publishers; 1976.Google Scholar
  7. Copeland EM, Miller LD, Smith GP. The complex nature of small bowel control of gastric secretion. Ann Surg. 1968;168:36–46.PubMedCentralCrossRefPubMedGoogle Scholar
  8. Copeland EM, MacFadyen BV, Dudrick SJ. Intravenous hyperalimentation in cancer patients. J Surg Res. 1974a;16:241–7.CrossRefPubMedGoogle Scholar
  9. Copeland EM, MacFadyen Jr BV, Dudrick SJ. Prevention of microbial catheter contamination in patients receiving hyperalimentation. South Med J. 1974b;67:303–7.CrossRefPubMedGoogle Scholar
  10. Copeland EM, MacFadyen Jr BV, McGown C, Dudrick SJ. The use of hyperalimentation in patients with potential sepsis. Surg Gynecol Obstet. 1974c;138:377–80.PubMedGoogle Scholar
  11. Copeland EM, MacFadyen Jr BV, Lanzotti V, Dudrick SJ. Intravenous hyperalimentation as an adjunct to cancer chemotherapy. Am J Surg. 1975;129:167–73.CrossRefPubMedGoogle Scholar
  12. Copeland EM, MacFadyen Jr BV, Dudrick SJ. Effect of intravenous hyperalimentation on established delayed hypersensitivity in the cancer patient. Ann Surg. 1976;184:60–4.PubMedCentralCrossRefPubMedGoogle Scholar
  13. Copeland EM, Dudrick SJ. Advances in parenteral nutrition. In: Johnston IDA, editor. Proceedings of an International Symposium held in Bermuda, 16–19th May 1977Google Scholar
  14. Copeland EM, Daly JM, Dudrick SJ. Nutritional concepts in the treatment of head and neck malignancies. Head Neck Surg. 1979;1:350–63.CrossRefPubMedGoogle Scholar
  15. Daly JM, Dudrick SJ, Copeland EM. Intravenous hyperalimentation. Effect on delayed cutaneous hypersensitivity in cancer patients. Ann Surg 1980:192, 587–92.Google Scholar
  16. De Cicco M, Panarello G, Fantin D, et al. Parenteral nutrition in cancer patients receiving chemotherapy: effects on nutritional status and toxicity. J Parenter Enteral Nutr. 1993;17:513–8.CrossRefGoogle Scholar
  17. Dudrick SJ, Vars HM, Rhoads JE. Growth of puppies receiving all nutritional requirements by vein, Fortschritte der Parenter. Ernahr. In: Symposium of the International society of Parenteral Nutrition in 1966, Fortshr Parenter Ernahr; Munchen, West Germany, 1967. p. 2Google Scholar
  18. Dudrick SJ, Wilmore DW, Vars HM, Rhoads JE. Can intravenous feeding as the sole means of nutrition support growth in the child and restore weight loss in the adult? An affirmative answer. Ann Surg. 1971;1071(121):169–73.Google Scholar
  19. Frazier TG, Copeland EM, Gallager SH, et al. Prognosis and treatment in minimal breast cancer. Am J Surg. 1977;133:697–701.CrossRefPubMedGoogle Scholar
  20. Hassenberg T, Essenbreis A, Herold A, et al. Early supplementation of parenteral nutrition is capable of improving quality of life, chemotherapy-related toxicity and body composition in patients with advanced colorectal carcinoma undergoing palliative treatment: results from a prospective, randomized clinical trial. Color Dis. 2010;12:e190–9.CrossRefGoogle Scholar
  21. Heatly RV, Hughes LE. Preoperative intravenous nutrition in cancer patients (abst). Proceedings of the XIth International Cancer Conference, Florence, Italy, 1975;4:874Google Scholar
  22. Johnson LR, Copeland EM, Dudrick SJ, et al. Structural and hormonal alterations in the gastrointestinal tract of parenterally fed rats. Gastroenterology. 1975;68:1177–83.PubMedGoogle Scholar
  23. Lanzotti VC, Copeland EM, George SL, et al. Cancer chemotherapeutic response and intravenous hyperalimentation. Cancer Chemother Rep. 1975;59:437–9.PubMedGoogle Scholar
  24. Lu C-Y, Shih S-L, Sun L-C, et al. Inflammatory modulation effect of glutamine-enriched total parenteral nutrition in postoperative gastrointestinal cancer patients. Am Surg. 2010;77:59–64.Google Scholar
  25. Muller JM, Dienst C, Brenner U, et al. Perioperative TPN in patients with upper gastrointestinal malignancies. Lancet. 1981;1:68–71.Google Scholar
  26. Ota DM, Cox LC, Martin S, Copeland EM. Ambulatory home intravenous hyperalimentation. Cancer Bull. 1982;34:218–22.Google Scholar
  27. Ryan AM, Reynolds JV, Healy L, et al. Enteral nutrition enriched with eicosapentaenoic Acid (EPA) preserves lean body mass following esophageal cancer surgery results of a double-blinded randomized controlled trial. Ann Surg. 2009;249:355–63.CrossRefPubMedGoogle Scholar
  28. Samuels ML, Selig DE, Ogden S, et al. IV hyperalimentation and chemotherapy for stage III testicular cancer: a randomized study. Cancer Treat Rep. 1981;65:615–28.PubMedGoogle Scholar
  29. Souba WW, Klimberg VS, Plumley DA, et al. The role of glutamine in maintaining a healthy gut and supporting the metabolic response to injury and infection. J Surg Res. 1990;48:383–91.CrossRefPubMedGoogle Scholar
  30. The Veterans Affairs Total Parenteral Nutrition Cooperative Study Group. Perioperative total parenteral nutrition in surgical patients. N Engl J Med. 1991;325:525–32.CrossRefGoogle Scholar
  31. Wang W, Jiang Z-M, Noln MT, et al. The impact of glutamine dipeptide-supplemented parenteral nutrition on outcomes of surgical patients: a meta-analysis of randomized trials. J Parenter Enteral Nutr. 2010;34:521–9.CrossRefGoogle Scholar
  32. Weisdorf SA, Lysne J, Wind D, et al. Positive effect of prophylactic total parenteral nutrition on long-term outcome of bone marrow transplantation. Transplantation. 1987;43:833–8.CrossRefPubMedGoogle Scholar
  33. Wertlind A, Ekman L, Moldawer L. New developments in lipid infusions for parenteral nutrition. Infusionther Klin Ernahr. 1987;3:4–8.Google Scholar
  34. Wilmore DW, Dudrick SJ. Safe long-term venous catheterization. Arch Surg. 1969;98:256–8.CrossRefPubMedGoogle Scholar
  35. Ziegler TR, Young LS, Benfell K, et al. Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation: a randomized, double-blind, controlled study. Ann Intern Med. 1992;116:821–8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.University of Florida College of MedicineGainesvilleUSA

Personalised recommendations